SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001600620-23-000029
Filing Date
2023-08-03
Accepted
2023-08-03 06:07:54
Documents
77
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q auph-20230630.htm   iXBRL 10-Q 1014688
2 EX-31.1 auph-2023q2exx311.htm EX-31.1 10869
3 EX-31.2 auph-2023q2exx312.htm EX-31.2 11011
4 EX-32.1 auph-2023q2exx321.htm EX-32.1 5336
5 EX-32.2 auph-2023q2exx322.htm EX-32.2 5344
  Complete submission text file 0001600620-23-000029.txt   5898117

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT auph-20230630.xsd EX-101.SCH 39646
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT auph-20230630_cal.xml EX-101.CAL 71015
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT auph-20230630_def.xml EX-101.DEF 151484
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT auph-20230630_lab.xml EX-101.LAB 598922
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT auph-20230630_pre.xml EX-101.PRE 367866
71 EXTRACTED XBRL INSTANCE DOCUMENT auph-20230630_htm.xml XML 817106
Mailing Address #140, 14315 - 118 AVENUE EDMONTON A0 T5L 4S6
Business Address #140, 14315 - 118 AVENUE EDMONTON A0 T5L 4S6 250-744-2487
Aurinia Pharmaceuticals Inc. (Filer) CIK: 0001600620 (see all company filings)

IRS No.: 981231763 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36421 | Film No.: 231137871
SIC: 2834 Pharmaceutical Preparations